| Financial Year |
March 31 2023 |
| Monetary Funds |
622,566,862.74 |
| Held-for-trading Financial Assets |
120,538,999.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
369,545,437.05 |
| Advances to Suppliers |
24,258,470.20 |
| Other Receivables |
100,114,408.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
26,452,787.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
31,402,228.29 |
| Other Current Assets |
133,147,730.57 |
| Total Current Assets |
1,443,119,090.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
32,269,455.50 |
| Long-term Equity Investment |
512,799,677.79 |
| Investment Properties |
630,837,679.52 |
| Fixed Assetes |
88,603,434.28 |
| Under-construction Projects |
6,981,638.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,208,233.87 |
| R&D expenses |
-- |
| Goodwill |
223,845,790.41 |
| Long-Term Deferred and Prepaid Expenses |
39,606,585.10 |
| Deferred Income Tax Assets |
3,534,050.53 |
| Other Non-Current Assets |
16,410,464.81 |
| Sub-Total of Non-Current Assets |
2,362,034,309.53 |
| Total Assets |
3,805,153,400.09 |
| Short-Term Loans |
181,290,644.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
34,370,932.98 |
| Accounts Payable |
312,983,503.78 |
| Accounts Received In Advance |
3,394,892.26 |
| Employee Compensation Payable |
65,338,983.63 |
| Taxes Payable |
7,422,490.04 |
| Interest Payable |
90,817.21 |
| Dividend Payable |
2,132,269.51 |
| Other payables |
260,928,421.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
195,202,407.63 |
| Other Current Liabilities |
276,669,301.51 |
| Sub-Total of Current Liabilities |
1,609,196,367.87 |
| Long-term Loans |
143,374,634.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
376,522.34 |
| Deferred Income Tax Liabilities |
1,171.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
369,995,621.55 |
| Total Liabilities |
1,979,191,989.42 |
| Paid-In Capital(Or Share Stock) |
1,017,698,410.00 |
| Capital Surplus |
-192,096,848.63 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
744,969,938.27 |
| Minority Stockholder's Interest |
257,891,553.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,568,069,856.92 |
| Owner's Equity（Stockholder's Equity） |
1,825,961,410.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,805,153,400.09 |
